-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Friday's Pre-Market Session
Share
Listen to the news

Gainers

  • Tenon Medical (NASDAQ:TNON) shares moved upwards by 49.2% to $7.91 during Friday's pre-market session. The company's market cap stands at $3.5 million.
  • Biodexa Pharmaceuticals (NASDAQ:BDRX) stock rose 25.66% to $0.83.
  • China SXT Pharmaceuticals (NASDAQ:SXTC) stock increased by 10.87% to $2.14. The company's market cap stands at $1.0 million.
  • Accuray (NASDAQ:ARAY) shares increased by 9.71% to $0.27. The company's market cap stands at $29.0 million.
  • Relmada Therapeutics (NASDAQ:RLMD) stock increased by 9.33% to $4.45. The market value of their outstanding shares is at $434.1 million.
  • Biofrontera (NASDAQ:BFRI) shares moved upwards by 8.21% to $1.58. The company's market cap stands at $21.6 million.

Losers

  • CDT Equity (NASDAQ:CDT) stock decreased by 22.4% to $0.27 during Friday's pre-market session. The company's market cap stands at $4.7 million.
  • Tempest Therapeutics (NASDAQ:TPST) shares fell 18.58% to $0.65. The company's market cap stands at $13.2 million.
  • Silexion Therapeutics (NASDAQ:SLXN) stock decreased by 18.28% to $0.35. The market value of their outstanding shares is at $2.3 million.
  • Radiopharm Theranostics (NASDAQ:RADX) stock decreased by 17.48% to $1.7. The company's market cap stands at $29.7 million.
  • Karyopharm Therapeutics (NASDAQ:KPTI) stock decreased by 16.05% to $1.36. The market value of their outstanding shares is at $36.7 million.
  • Beta Bionics (NASDAQ:BBNX) shares declined by 8.32% to $15.21. The company's market cap stands at $746.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending